Logo

Concord Biotech Share Price

Concord Biotech (INR)2151.0515.2   (0.7%)

Exchange ScripsBSE543960NSECONCORDBIOISININE338H01029

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Concord Biotech Performance

Market performance
Open price2128.25
High2182
Volumes24792
Prev Close2151.05
Low2099.9
Closing date2024-12-24
Historical performance
1 Year High2664.00
3 Year High2664.00
5 Year High2664.00
1 Year Low1327.05
3 Year Low900.05
5 Year Low900.05

Concord Biotech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
22287
Face Value
Face Value (₹)
1
P/E Ratio
P/E Ratio
73.04
Dividend Yield
Dividend Yield
0.41 %

Concord Biotech Investment Returns

1 Year
43%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Concord Biotech Technicals

IndicatorsValueSignal
5-DMA2142.97Bullish
10-DMA2132.6Bullish
20-DMA2134.13Bullish
50-DMA1991.63Bullish
100-DMA1914.62Bullish
200-DMA1728.6Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters66666
Foreign Investors---------------
Domestic Investors66666
Public Investors84292807318329087480100921
Government---------------

Concord Biotech Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income338353234138
Operating Profit4660383929733417
Interest32986110
Depreciation536540500275
Profit Before Tax4126322023753127
Consolidated Net Profit3081240117492348
Adjusted EPS29231722

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital1051059595
Total Reserves1516212795109379899
Minority Interest------------
Total Non-Current Liabilities319321544774
Total Liabilities17007151401501913127
Capital Work in Progress21151727742179
Total Assets17007151401501913127

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities2655246020751668
Cash Flow from Investing Activities-1546-1580-1118-1952
Cash Flow from Financing Activitie-992-852-1002311
Net Cash Inflow / Outflow11628-4527
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 73.04.
  • 3Y Stock Price CAGR of the stock is 128.2.
  • The stock has a beta of 0.6.
  • In the last financial year, the company had an EBITDA of ₹4660 Million.
  • The company generated revenue of ₹10169 Million in the previous financial year.

Concord Biotech

2151.0515.2   (0.7%)

Investment Amount: ₹ 150610
Current Value: ₹ 215105
Performance: 42.8%
P/L: ₹ 64495
Top Gainers
SymbolChange%
KOHINOOR48.4(20%)
AMNPLST313.65(20%)
MOBIKWIK608.9(15%)
BIRLAMONEY294.76(14%)
TRF474.3(13%)
Top Losers
SymbolChange%
SADHNANIQ46.52(-14%)
SAMBHAAV8.2(-9%)
PVP29.92(-8%)
BSL305.61(-7%)
THEJO2082(-6%)
SETUINFRA0.88(-5%)
TPHQ2.34(-5%)
INDOUS273.4(-5%)
Similar stocks

Zota Health Care

46.6

827.7

November 25 - December 25

Bajaj Healthcare

44.9

567.3

November 25 - December 25

Ind-Swift

31.3

26.91

November 25 - December 25

Vimta Labs

30.4

996.05

November 25 - December 25

Lincoln Pharma

29.8

802.3

November 25 - December 25

Orchid Pharma

23.2

1797.4

November 25 - December 25

Wanbury

22.3

270.67

November 25 - December 25

Caplin Point Lab

22.1

2397.15

November 25 - December 25

Announcing Stock of the Month!

Stock of the Month
Stock of the Month